Mitchell E Gross
Overview
Explore the profile of Mitchell E Gross including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
858
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chambliss A, Aljehani M, Tran B, Chen X, Elton E, Garri C, et al.
Pract Lab Med
. 2023 Aug;
36:e00323.
PMID: 37649544
Objectives: We sought to identify immune biomarkers associated with severe Coronavirus disease 2019 (COVID-19) in patients admitted to a large urban hospital during the early phase of the SARS-CoV-2 pandemic....
2.
Welter L, Zheng S, Setayesh S, Morikado M, Agrawal A, Nevarez R, et al.
Cancers (Basel)
. 2023 Aug;
15(15).
PMID: 37568766
Bi-directional crosstalk between the tumor and the tumor microenvironment (TME) has been shown to increase the rate of tumor evolution and to play a key role in neoplastic progression, therapeutic...
3.
Jacobs M, Olivero J, Ok Choi H, Liao C, Kashemirov B, Katz J, et al.
Bioorg Med Chem
. 2023 Aug;
92:117425.
PMID: 37544256
Monoamine oxidases (MAOA/MAOB) are enzymes known for their role in neurotransmitter regulation in the central nervous system (CNS). Irreversible and non-selective MAO inhibitors (MAOi's) were the first class of antidepressants,...
4.
Dawson J, Dorff T, Tuzon C, Rice J, Schroeder E, Lane C, et al.
Integr Cancer Ther
. 2021 Jul;
20:15347354211035442.
PMID: 34301165
Purpose: Prostate cancer survivors (PCS) receive androgen deprivation therapy (ADT) as treatment for recurrent cancer, yet ADT is associated with loss of skeletal muscle and physical function. Resistance training can...
5.
Trac N, Chen L, Zhang A, Liao C, Poon C, Wang J, et al.
J Control Release
. 2020 Oct;
329:614-623.
PMID: 33011241
Signaling between the CC chemokine receptor 2 (CCR2) with its ligand, monocyte chemoattractant protein-1 (MCP-1) promotes cancer progression by directly stimulating tumor cell proliferation and downregulating the expression of apoptotic...
6.
Gross M, Agus D, Dorff T, Pinski J, Quinn D, Castellanos O, et al.
Prostate Cancer Prostatic Dis
. 2020 Mar;
24(1):61-68.
PMID: 32123315
Purpose: Monoamine oxidase A (MAOA) influences prostate cancer growth and metastasis in pre-clinical models. We examined effects of phenelzine (a monoamine oxidase inhibitor) in patients with biochemical recurrent castrate-sensitive prostate...
7.
Dorff T, Quinn D, Pinski J, Goldkorn A, Sadeghi S, Tsao-Wei D, et al.
Clin Genitourin Cancer
. 2019 Jun;
17(4):241-247.e1.
PMID: 31227432
Background: Signaling via the Src pathway is thought to be a mediator of resistance to androgen targeted therapy in prostate cancer. We studied whether adding the Src inhibitor dasatinib to...
8.
Patsch K, Matasci N, Soundararajan A, Diaz P, Agus D, Ruderman D, et al.
BMC Res Notes
. 2019 May;
12(1):275.
PMID: 31092276
Objective: Cell-free DNA (cfDNA) is an attractive cancer biomarker, as it is thought to reflect a component of the underlying genetic makeup of the tumor and is readily accessible in...
9.
Gaur S, Gross M, Liao C, Qian B, Shih J
Prostate
. 2019 Jan;
79(6):667-677.
PMID: 30693539
Background: Monoamine oxidase A (MAOA) is best known for its role in neuro-transmitter regulation. Monoamine oxidase inhibitors are used to treat atypical depression. MAOA is highly expressed in high grade...
10.
Tiemann K, Garri C, Lee S, Malihi P, Park M, Alvarez R, et al.
Oncogene
. 2018 Dec;
38(16):3003-3018.
PMID: 30575818
Anterior gradient 2 (AGR2) is a member of the protein disulfide isomerase (PDI) family, which plays a role in the regulation of protein homeostasis and the unfolded protein response pathway...